- €21.28bn
- €62.38bn
- €44.74bn
- 50
- 80
- 65
- 74
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 143,755 | 26,792 | 33,617 | 41,844 | 44,742 |
Cost of Revenue | |||||
Gross Profit | 23,296 | 6,227 | 7,962 | 10,129 | 12,471 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 135,574 | 26,719 | 28,838 | 35,452 | 36,907 |
Operating Profit | 8,181 | 73 | 4,779 | 6,392 | 7,835 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6,820 | -214 | 4,653 | 5,896 | 7,872 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,985 | 319 | 3,351 | 4,836 | 6,777 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,053 | -30 | 1,718 | 4,227 | 4,194 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,053 | -30 | 1,717 | 4,227 | 4,194 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.66 | 8.4 | 7.84 | 13.2 | 19.5 |
Dividends per Share |